Clinical Pharmacology & Therapeutics · 1966 · 11 citations · 0 references
PharmacyPharmacologyPharmacotherapyClinical PharmacologyPharmacodynamicsRespiratory PharmacotherapyAntitussive TherapyBronchodilator TherapyChronic CoughCough ManagementAntitussive EfficacyAntitussive SafetyChronic Cough ManagementCough PhysiologyExperimental StudiesPharmacologic Cough TreatmentPrescription AntitussivesRespiratory Antitussives
Pipazethate, thiophenylpyridylamine‐10‐carboxylic acid‐piperidinoethoxyethylester‐HCl, has been reported to have significant antitussive activity in clinical and experimental studies. In a double‐blind study, the drug has been compared with placebo in 70 patients with cough and in 41 healthy subjects in whom cough was artificially induced. The method of Bickerman and Barach was successfully used to induce artificial cough. The present trial suggests that results with pipazethate are no better than with placebo in experimental studies as well as in clinical studies of chronic cough.